The Relationship between Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-small Cell Lung Cancer

doi:10.7517/issn.1674-0475.200206

Abstract

Abstract: In this study,the relationship between enhanced CT parameters and clinicpathological characteristics of non-small cell lung cancer was analyzed,and the factors influencing the prognosis were discussed. The results showed that tumor size, CT enhancement, number of lymph node enlargement, and lymph node size were related to the degree of non-small cell lung cancer differentiation, TNM staging, and lymph node metastasis. The large tumor size, lymphadenopathy, tumor CT enhancement, and lymph node metastasis are associated with poor prognosis,and are independent risk factors for prognosis. It indicates that enhanced CT parameters are correlated with the clinicopathological characteristics of patients with non-small cell lung cancer and can predict the prognosis of patients with non-small cell lung cancer.

Key words: enhanced CT, non-small cell lung cancer, clinicopathological features, prognosis

WU Tao, CHEN Jiang. The Relationship between Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-small Cell Lung Cancer[J]. Imaging Science and Photochemistry, 2020, 38(4): 734-738.

References

[1] Heo S J, Jung I, Lee C K, et al. A randomized phase Ⅱ trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer[J]. Cancer Chemotherapy Pharmacology, 2016, 77(3):539-548.
[2] Dela C C S, Tanoue L T, Matthay R A. Lung cancer:epidemiology, etiology, and prevention[J]. Clinic in Chest Medicine, 2011, 32(4):605-644.
[3] Tang S, Pan Y, Wang Y, et al. Genome-wide association study of survival in early-stage non-small cell lung cancer[J]. Annals Surgical Oncology, 2015, 22(2):630-635.
[4] Xu Y H, Lu S. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with nonsmall-cell lung cancer[J]. European Journal of Surgical Oncology, 2014, 40(3):311-317.
[5] Yang M, Cao H, Guo X, et al. The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer[J]. PLoS One, 2013, 8(9):e73220.
[6] Nwogu CE, Groman A, Fahey D, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer[J]. The Annals of Thoracic Surgery, 2012, 93(5):1614-1619.
[7] Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning[J]. Thorax, 2011, 66(4):315-319.
[8] Al-Kadi O S. Assessment of texture measures susceptibility to noise in conventional and contrast enhanced computed tomography lung tumour images[J]. Computerized Medical Imaging and Graphics, 2010, 34(6):494-503.
[9] Pfluger T, Melzer H I, Schneider V, et al. PET/CT in malignant melanoma:contrast-enhanced CT versus plain low-dose CT[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38(5):822-831.
[10] Lyv Y L, Yuan D M, Wang K, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer:a bivariate systematic review and meta-analysis[J]. Journal of Thoracic Oncology, 2011, 6(8):1350-1358.
[11] Huellner M W, de Galiza Barbosa F, Husmann L, et al. TNM staging of non-small cell lung cancer:comparison of PET/MR and PET/CT[J]. Journal of Nuclear Medicine, 2016, 57(1):21-26.
[12] Baba T, Uramoto H, Kuwata T, et al. A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or less[J]. Scandinavian Journal of Surgery, 2011, 100(3):153-158.
[13] Donnem T, Hald S M, Paulsen E E, et al. Stromal CD8+ T-cell density-a promising supplement to TNM staging in non-small cell lung cancer[J]. Clinical Cancer Research, 2015, 21(11):2635-2643.
[14] Shien K, Toyooka S, Soh J, et al. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division[J]. Interactive Cardiovascular and Thoracic Surgery, 2015, 20(6):791-796.
[15] Liu X H, Liu Z L, Sun M, et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer[J]. BMC Cancer, 2013, 13:464.
[16] Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacitydominant clinical stage IA lung adenocarcinoma:wedge resection or segmentectomy[J]. Chest, 2014, 145(1):66-71.
[17] Stojiljkovic D, Santrac N, Stojiljkovic T, et al. Correlation of tumor size as independent factor and disease stage with local recurrence of non-small cell lung carcinoma and its operability[J]. Journal of BUON, 2015, 20(1):166-172.
[18] Kang S, Kim Y S, Choi H J, et al. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in earlystage cervical cancer patients[J]. Journal of Computer Assisted Tomography, 2013, 37(4):572-576.
[19] Osarogiagbon R U, Eke R, Sareen S, et al. The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens[J]. Annals of Diagnostic Pathology, 2014, 18(4):220-226.
[20] Agarwal M, Brahmanday G, Chmielewski G W, et al. Age, tumor size, type of surgery, and gender predict survival in early stage (stage Ⅰ and Ⅱ) non-small cell lung cancer after surgical resection[J]. Lung Cancer, 2010, 68(3):398-402.
[21] Tateishi Y, Nakanishi Y, Taniguchi H, et al. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma[J]. Modern Pathology, 2010, 23(8):1068-1072.
[22] Dai C, Ren Y, Xie D, et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease?[J].Journal of Thoracic Oncology, 2016, 11(10):1745-1754.